Nanoparticle albumin-bound paclitaxel can be useful agent to advanced primary mucinous carcinoma of the skin

被引：2
|
作者：
Homma, E. [1 ]
Hata, H. [1 ]
Tsujiwaki, M. [1 ]
Aoyagi, S. [1 ]
Shimizu, H. [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2015年 / 29卷 / 11期
关键词：
ADENOCYSTIC CARCINOMA;
D O I：
10.1111/jdv.12574
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：2271 / 2273
页数：3
相关论文
共 50 条
  • [41] Binding affinities of paclitaxel and docetaxel for generic and nanoparticle albumin-bound paclitaxel-derived albumin from human serum
    Sato, Takamichi
    Okazaki, Manami
    Sano, Junko
    Kato, Chihiro
    Shimizu, Kazuhisa
    Kitagawa, Masayuki
    [J]. BIOMEDICAL REPORTS, 2021, 14 (04)
  • [42] Superior therapeutic efficacy of nanoparticle albumin-bound paclitaxel over cremophor-bound paclitaxel in experimental esophageal adenocarcinoma
    Hassan, Md Sazzad
    Awasthi, Niranjan
    Schwarz, Roderich E.
    Schwarz, Margaret A.
    von Holzen, Urs
    [J]. CANCER RESEARCH, 2017, 77
  • [43] Interim results of PEANUT: pembrolizumab and nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC)
    Necchi, Andrea
    Raggi, Daniele
    Bandini, Marco
    Fare, Elena
    Giannatempo, Patrizia
    Colecchia, Maurizio
    Pederzoli, Filippo
    Gallina, Andrea
    Marandino, Laura
    Calareso, Giuseppina
    Madison, Russell
    Briganti, Alberto
    Ross, Jeffrey S.
    Montorsi, Francesco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [44] Final results of PEANUT: Pembrolizumab and nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC).
    Giannatempo, Patrizia
    Calareso, Giuseppina
    Bandini, Marco
    Marandino, Laura
    Raggi, Daniele
    Fare, Elena
    Colecchia, Maurizio
    Pederzoli, Filippo
    Gallina, Andrea
    Madison, Russell
    Briganti, Alberto
    Ross, Jeffrey S.
    Montorsi, Francesco
    Necchi, Andrea
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Radiation-guided drug delivery of nanoparticle albumin-bound paclitaxel to lung cancer
    Hariri, G.
    Han, Z.
    Hallahan, D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S705 - S706
  • [46] Retrospective comparisons of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for breast cancer
    Li, Yan
    Chen, Xiang
    Zhu, Qiannan
    Chen, Rui
    Xu, Lu
    Li, Shuo
    Shi, Xiaoqing
    Xu, Haiping
    Xu, Yinggang
    Zhang, Weiwei
    Huang, Xiaofeng
    Zha, Xiaoming
    Wang, Jue
    [J]. NANOMEDICINE, 2021, 16 (05) : 391 - 400
  • [47] Hemorrhagic cystitis in gastric cancer after nanoparticle albumin-bound paclitaxel: A case report
    Zhang, Xin-Jie
    Lou, Jian
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (03)
  • [48] In vivo radiation enhancement by ABI-007, a nanoparticle albumin-bound (nab) paclitaxel
    Wiedenmann, N.
    Valdecanas, D.
    Farrar, D.
    Milas, L.
    Mason, K.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 13 - 14
  • [49] ABI-007, nanoparticle albumin-bound paclitaxel, enhances tumor radioresponse.
    Mason, Kathy A.
    Wiedenmann, Nicole
    Valdecanas, David
    Buchholz, Thomas
    Milas, Luka
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [50] Risk factors for neutropenia during gemcitabine and nanoparticle albumin-bound paclitaxel combination chemotherapy
    Yoneyama, Hiroshi
    Sasaki, Hisako
    Sugawara, Mitsuhiro
    Sasaki, Jiichiro
    Atsuda, Koichiro
    [J]. ANNALS OF ONCOLOGY, 2017, 28
12345